
2026 Predictions for Clinical Labs: AI, Audits, and Increased Enforcement
How clinical laboratories should prepare for the next wave of oversight in the new year

How clinical laboratories should prepare for the next wave of oversight in the new year

Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior


Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance